Evidence map›Paper›PMID 24302559›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2014

Optical imaging of mitochondrial redox state in rodent models with 3-iodothyronamine.

Zahra Ghanian, Sepideh Maleki, Hannah Reiland, Daniel E Bütz, Grazia Chiellini, Fariba M Assadi-Porter, Fariba-Assadi Porter, Mahsa Ranji

Erratum issuedAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

  • Erratum issued
    Porter, Fariba-Assadi [corrected to Assadi-Porter, Fariba M]
5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zahra GhanianBiophotonics Laboratory, Department of Electrical Engineering and Computer Science, University of Wisconsin Milwaukee, Milwaukee, WI 53211-3029, USA.
Sepideh Maleki
Hannah Reiland
Daniel E Bütz
Grazia Chiellini
Fariba M Assadi-Porter
Fariba-Assadi Porter
Mahsa Ranji
University of Wisconsin–Madison · USUniversity of Wisconsin–Milwaukee · US

Funding

Integrated Multidisciplinary Strategies for Detection of Diabetic RetinopathiesRC4EY021357 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ASSADI, AMIR H, ASSADI-PORTER, FARIBA M · 2010 to 2010
$3.2M
The sweet protein brazzein and its interaction with the human taste receptorR01DC009018 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI ASSADI-PORTER, FARIBA M · 2008 to 2012
$1.6M
Clinical and Translational Science AwardKL2TR000056 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI SHAKER, REZA NONE · 2012 to 2015
$609k
NCATS NIH HHS 8KL2TR000056NCATS NIH HHS KL2 TR000056NEI NIH HHS RC4 EY021357NEI NIH HHS RC4EY021357-01NIDCD NIH HHS 1R01 DC009018NIDCD NIH HHS R01 DC009018
6 · The paper itself

Abstract

This study used an optical technique to measure the effects of treating low (10 mg/kg) and high (25 mg/kg) doses of 3-iodothyronamine (T₁AM) on the metabolism in the kidney and heart of mice. The ratio of two intrinsic fluorophores in tissue, (NADH/FAD), called the NADH redox ratio (NADH RR), is a marker of the metabolic state of the tissue. A cryofluorescence imaging instrument was used to provide a quantitative assessment of NADH RR in both kidneys and hearts in mice treated with 3-iodothyronamine. We compared those results to corresponding tissues in control mice. In the kidneys of mice treated with a high dose T₁AM, the mean values of the maximum projection of NADH RR were 2.6 ± 0.6 compared to 3.20 ± 0.03 in control mice, indicating a 19% (± 0.4) significant increase in oxidative stress (OS) in the high dose-treated kidneys (P = 0.047). However, kidneys treated with a low dose of T₁AM showed no difference in NADH RR compared to the kidneys of control mice. Furthermore, low versus high dose treatment of T₁AM showed different responses in the heart than in the kidneys. The mean value of the maximum projection of NADH RR in the heart changed from 3.0 ± 0.3 to 3.2 ± 0.6 for the low dose and the high dose T₁AM-treated mice, respectively, as compared to 2.8 ± 0.7 in control mice. These values correspond to a 9% (±0.5) (P = 0.045) and 14% (±0.5) (P = 0.008) significant increase in NADH RR in the T₁AM-treated hearts, indicating that the high dose T₁AM-treated tissues have reduced OS compared to the low dose-treated tissues or the control tissues. These results suggest that while T₁AM at a high dose increases oxidative response in kidneys, it has a protective effect in the heart and may exert its effect through alternative pathways at different doses and at tissue specific levels.

Indexed as

Oxidative StressAnimalsAnimals, Outbred StrainsFemaleHeartKidneyMiceMitochondriaMyocardiumOptical ImagingOxidation-ReductionThyronines3-iodothyronamineThyronines3-IodothyronamineFADmitochondrial redox ratioNADHoptical imagingoxidative stress

Identifiers

PMID24302559
PMCPMC5020697
OpenAlexW2057849674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.